AZTH / NYSE
$187.42
▲ +3.28 (+1.78%)
As of 4:00 PM EST, Jan 15, 2026
Market Cap
$2.34T
P/E Ratio
24.6
Dividend Yield
1.82%
EPS (TTM)
$7.62
52-Week Range
$124.10 — $198.75

Key Financial Metrics

Total Revenue
$94.2B
▲ 12.4% YoY
Net Income
$18.7B
▲ 18.1% YoY
Operating Margin
24.3%
▲ 2.1pp YoY
Free Cash Flow
$21.4B
▲ 15.7% YoY
Total Assets
$142.8B
▲ 8.9% YoY
R&D Expenditure
$12.1B
▲ 22.3% YoY

AZTH Stock Performance

$200 $160 $120 $80 $40 2021 2022 2023 2024 2025 2026

Revenue by Division

Revenue Split (FY2025)

Technology 30%
Energy 20%
Aerospace 15%
Healthcare 10%
Finance 15%
Other Divisions 10%

Revenue Contribution

Technology & Digital $28.3B
Energy & Power $18.8B
Aerospace & Defense $14.1B
Health Sciences $9.4B
Capital Group $14.1B
All Other Divisions $9.5B

Quarterly Earnings Data

Quarter Revenue Net Income EPS YoY Growth Margin
Q4 2025 $25.1B $5.2B $1.94 +14.2% 20.7%
Q3 2025 $23.8B $4.8B $1.79 +11.8% 20.2%
Q2 2025 $22.9B $4.5B $1.68 +10.3% 19.7%
Q1 2025 $22.4B $4.2B $1.57 +9.7% 18.8%
Q4 2024 $22.0B $4.0B $1.48 +8.1% 18.2%
Q3 2024 $21.3B $3.9B $1.43 +7.4% 18.3%
Q2 2024 $20.8B $3.7B $1.37 +6.8% 17.8%
Q1 2024 $20.1B $3.5B $1.29 +5.9% 17.4%

Dividend Information

Aevum Zenth has paid consecutive quarterly dividends for 18 years, with a compound annual growth rate of 14.2%.

Quarterly Dividend
$0.85
Annual Dividend
$3.40
Yield
1.82%
Ex-Dividend Date
Feb 15, 2026
Payment Date
Mar 1, 2026

Analyst Ratings & Price Targets

Goldman Sachs
Overweight

"AZTH's diversified revenue streams and dominant market position in AI infrastructure make it a top pick for 2026. Strong execution across aerospace and energy divisions."

Price Target $220.00
Morgan Stanley
Buy

"Innovation across 40 subsidiaries drives compounding returns. Quantum computing division is a sleeper giant. Initiating at Buy."

Price Target $210.00
JP Morgan
Buy

"Fusion energy breakthrough combined with AI dominance creates a rare dual-catalyst setup. Raising price target on strong Q4 results."

Price Target $205.00
Bank of America
Buy

"Healthcare division's gene therapy pipeline and aerospace contracts position AZTH for sustained double-digit growth. Upside from current levels."

Price Target $198.00
Citigroup
Hold

"Solid fundamentals but valuation is getting rich at current multiples. Prefer to wait for a pullback to $165 to initiate. Maintaining Hold."

Price Target $185.00
Barclays
Overweight

"AZTH's robotics division captured in autonomous vehicle transition. Revenue visibility extends through 2030. Strong buy thesis."

Price Target $215.00

Share Information

Key Executives

VH
Victoria Hargrove
Chairwoman & CEO
Founded in 2031. Previously led Quantum Dynamics Corp.
MK
Marcus Kimura
Chief Financial Officer
25+ years in investment banking & strategic finance.
AN
Aisha Nwosu
Chief Operating Officer
Oversees 400+ subsidiary operations globally.
DR
Daniel Reeves
Chief Strategy Officer
Drives M&A and cross-divisional integration.

Financial Reports

Investor Relations Portal

Access comprehensive investor materials, set up price alerts, and manage your shareholder account.